These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 2926241)
1. Characterization of a novel myeloma cell line, MM.1. Goldman-Leikin RE; Salwen HR; Herst CV; Variakojis D; Bian ML; Le Beau MM; Selvanayagan P; Marder R; Anderson R; Weitzman S J Lab Clin Med; 1989 Mar; 113(3):335-45. PubMed ID: 2926241 [TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of a new human Bence Jones-type myeloma cell line, NOP-2. Nagai T; Ogura M; Morishita Y; Okumura M; Kato Y; Morishima Y; Hirabayashi N; Ohno R; Saito H Int J Hematol; 1991 Apr; 54(2):141-9. PubMed ID: 1747447 [TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of two human myeloma cell lines secreting kappa light chains. Eton O; Scheinberg DA; Houghton AN Leukemia; 1989 Oct; 3(10):729-35. PubMed ID: 2506399 [TBL] [Abstract][Full Text] [Related]
4. The establishment of an interleukin-6-dependent myeloma cell line (FLAM-76) carrying t(11;14)(q13;q32) chromosome abnormality from an aggressive nonsecretory plasma cell leukemia. Kubonishi I; Seto M; Shimamura T; Enzan H; Miyoshi I Cancer; 1992 Sep; 70(6):1528-35. PubMed ID: 1516003 [TBL] [Abstract][Full Text] [Related]
5. Establishment of a new human myeloma cell line, KMS-18, having t(4;14)(p16.3;q32.3) derived from a case phenotypically transformed from Ig A-lambda to BJP-lambda, and associated with hyperammonemia. Otsuki T; Nakazawa N; Taniwaki M; Yamada O; Sakaguchi H; Wada H; Yawata Y; Ueki A Int J Oncol; 1998 Mar; 12(3):545-52. PubMed ID: 9472091 [TBL] [Abstract][Full Text] [Related]
6. [Comparative study of genetic aberrations in human multiple myeloma cell lines and newly diagnosed MM by fluorescence in situ hybridization]. An G; Xie ZQ; Li CH; Li Q; Yi SH; Qiu LG Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1505-10. PubMed ID: 21176360 [TBL] [Abstract][Full Text] [Related]
7. Establishment and phenotypic characterization of three new human myeloma cell lines (U-1957, U-1958, and U-1996). Jernberg H; Nilsson K; Zech L; Lutz D; Nowotny H; Scheirer W Blood; 1987 Jun; 69(6):1605-12. PubMed ID: 3580570 [TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization. Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743 [TBL] [Abstract][Full Text] [Related]
10. Establishment and biological characteristics of human multiple myeloma cell line CZ-1. Hou J; Lin FY; Zhang B; Zhang LZ; Ding SQ Chin Med J (Engl); 2004 Jan; 117(1):115-9. PubMed ID: 14733786 [TBL] [Abstract][Full Text] [Related]
11. Two distinct human myeloma cell lines originating from one patient with myeloma. Katagiri S; Yonezawa T; Kuyama J; Kanayama Y; Nishida K; Abe T; Tamaki T; Ohnishi M; Tarui S Int J Cancer; 1985 Aug; 36(2):241-6. PubMed ID: 3926660 [TBL] [Abstract][Full Text] [Related]
12. A novel human multiple myeloma-derived cell line, NCU-MM-1, carrying t(2;11)(q11;q23) and t(8;22)(q24;q11) chromosomal translocations with overexpression of c-Myc protein. Iida S; Hanamura I; Suzuki T; Kamiya T; Kato M; Hayami Y; Miura K; Harada S; Tsuboi K; Wakita A; Akano Y; Taniwaki M; Nitta M; Ueda R Int J Hematol; 2000 Jul; 72(1):85-91. PubMed ID: 10979215 [TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of a human plasma cell myeloma culture having a rearranged cellular myc proto-oncogene. Gazdar AF; Oie HK; Kirsch IR; Hollis GF Blood; 1986 Jun; 67(6):1542-9. PubMed ID: 2423157 [TBL] [Abstract][Full Text] [Related]
14. Induction of CD28 on the new myeloma cell line MOLP-8 with t(11;14)(q13;q32) expressing delta/lambda type immunoglobulin. Matsuo Y; Drexler HG; Harashima A; Okochi A; Hasegawa A; Kojima K; Orita K Leuk Res; 2004 Aug; 28(8):869-77. PubMed ID: 15203285 [TBL] [Abstract][Full Text] [Related]
15. Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma. Chesi M; Kuehl WM; Bergsagel PL Ann Oncol; 2000; 11 Suppl 1():131-5. PubMed ID: 10707795 [TBL] [Abstract][Full Text] [Related]
16. Characterization of a new human multiple myeloma cell line, UMJF-2, which suppresses antibody production by B-lymphocytes in vitro. Farnen JP; Tyrkus M; Hanson CA; Cody RL; Emerson SG Leukemia; 1991 Jul; 5(7):574-84. PubMed ID: 1649357 [TBL] [Abstract][Full Text] [Related]
17. Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes. Mohamed AN; Bentley G; Bonnett ML; Zonder J; Al-Katib A Am J Hematol; 2007 Dec; 82(12):1080-7. PubMed ID: 17654686 [TBL] [Abstract][Full Text] [Related]
18. Effects of Epstein-Barr virus infection on the development of multiple myeloma after liver transplantation. Zhang Y; Zhao H; He X; Zheng S; Wang T; Yan D; Sun J; Lu X; Wen J; Lau WY Sci China Life Sci; 2012 Aug; 55(8):735-43. PubMed ID: 22932889 [TBL] [Abstract][Full Text] [Related]
19. [Establishment and biological characteristics of human multiple myeloma cell line CZ-1]. Hou J; Zhang B; Zhang L; Ding S Zhonghua Xue Ye Xue Za Zhi; 2002 Oct; 23(10):509-13. PubMed ID: 12482345 [TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of a permanent human IgA2/kappa myeloma cell line. Lohmeyer J; Hadam M; Santoso S; Förster W; Schulz A; Pralle H Br J Haematol; 1988 Jul; 69(3):335-43. PubMed ID: 3136791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]